论文部分内容阅读
目的 :探讨缬沙坦联合肾炎康复片治疗肾小球肾炎蛋白尿的临床效果。方法 :选取2012年8月2014年12月来我院肾内科就诊的116例肾小球肾炎患者为研究对象,随机分为观察组和对照组,每组58例。对照组在常规治疗的基础上服用缬沙坦,观察组在对照组的基础上再加服用肾炎康复片,疗程均为3个月。比较两组治疗前后24h尿蛋白量、日平均血压(收缩压)和血肌酐水平;比较两组治疗有效率。结果 :两组治疗后24h尿蛋白量、日平均血压、血脂和血肌酐均有所改善,但观察组改善效果优于对照组,差异具有统计学意义。结论 :缬沙坦联合肾炎康复片能减轻肾小球肾炎蛋白尿患者症状,且比单用缬沙坦效果较好,此联合方案值得推广。
Objective: To investigate the clinical effect of valsartan combined with nephritis kang tablet in the treatment of glomerulonephritis proteinuria. Methods: A total of 116 patients with glomerulonephritis treated in our hospital from December 2012 to December 2014 were randomly divided into observation group and control group, 58 cases in each group. In the control group, valsartan was taken on the basis of routine treatment. The observation group was given nephritis rehabilitation tablet on the basis of the control group again for 3 months. The levels of urinary protein, mean daily blood pressure (SBP) and serum creatinine were compared between the two groups before and after treatment. The treatment efficiency was compared between the two groups. Results: The urinary protein, daily mean blood pressure, blood lipid and serum creatinine were all improved 24 h after treatment, but the improvement effect in the observation group was better than that in the control group, the difference was statistically significant. Conclusion: Valsartan combined with nephritis can relieve the symptoms of glomerulonephritis patients with proteinuria, and better than valsartan alone, this combination is worth promoting.